I initiate coverage on Haleon with a "hold" rating due to decent results and potential for ongoing growth, despite a slight revenue slip last year. Haleon's dividend grew 10% and is well-covered ...

Consumer healthcare giant Haleon has reported a strong financial performance for 2024, with organic revenue growth of five per cent. However, revenue declined by 0.6 per cent on a reported basis ...

February 27, 2025 Sensodyne maker Haleon says 2025 revenue growth skewed to second half British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted ...

Shares of HLN opened at $10.45 on Wednesday. Haleon has a 12 month low of $7.89 and a 12 month high of $10.80. The company has a 50-day moving average price of $9.66 and a two-hundred day moving ...

Wide-moat Haleon reported solid fourth-quarter earnings that came largely in line with our expectations. Total sales of GBP 2.8 billion was down 0.3% but was up 6.8% organically with 2.7% from ...